BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38341204)

  • 21. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
    Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
    Trials; 2023 May; 24(1):367. PubMed ID: 37259112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for developing a core outcome set for evaluating school-based physical activity interventions in primary schools.
    Foley KA; Venkatraman T; Ram B; Ells L; van Sluijs E; Hargreaves DS; Greaves F; Taghavi Azar Sharabiani M; Viner RM; Bottle A; Saxena S
    BMJ Open; 2019 Dec; 9(12):e031868. PubMed ID: 31852702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
    Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
    Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing a core outcome set for neurogenic bladder trials: study protocol for a scoping review and Delphi surveys.
    Zhang Y; Chen Y; Niu M; Li Y; Zhang J; Zhang L; Wu F; Chen Q; Yu H; Tian J
    Trials; 2022 Jun; 23(1):485. PubMed ID: 35698096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of core outcome sets of Food for Special Medical Purposes designed for type 2 diabetes mellitus: a study protocol.
    Mu D; Gong J; Wei Y; Chen M; Yu J; Du L; Hu W
    Trials; 2023 Mar; 24(1):223. PubMed ID: 36959627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for the development of a core outcome set for clinical trials in primary sclerosing cholangitis.
    Hussain N; Ma C; Hirschfield G; Walmsley M; Hanford P; Vesterhus M; Kowdley K; Bergquist A; Ponsioen C; Levy C; Assis D; Schramm C; Bowlus C; Trauner M; Aiyegbusi OL; Jairath V; Trivedi PJ
    BMJ Open; 2024 Jun; 14(6):e080143. PubMed ID: 38926149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of reporting guidance and core outcome sets for seamless, standardised evaluation of innovative surgical procedures and devices: a study protocol for content generation and a Delphi consensus process (COHESIVE study).
    Avery K; Blazeby J; Wilson N; Macefield R; Cousins S; Main B; Blencowe NS; Zahra J; Elliott D; Hinchliffe R; Potter S
    BMJ Open; 2019 Sep; 9(9):e029574. PubMed ID: 31515426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What should be measured and reported in clinical trials for the treatment of patients with acute pancreatitis? A study protocol for establishing a core outcome set.
    Shen Y; Hu C; Li L; Chen Z; Chen W; Lin Z; Zhu P; Tan Q; Huang W; Sun X; Deng L; Xia Q
    BMJ Open; 2023 Dec; 13(12):e075859. PubMed ID: 38070929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a core outcome set for multimorbidity trials in low/middle-income countries (COSMOS): study protocol.
    Boehnke JR; Rana RZ; Kirkham JJ; Rose L; Agarwal G; Barbui C; Chase-Vilchez A; Churchill R; Flores-Flores O; Hurst JR; Levitt N; van Olmen J; Purgato M; Siddiqi K; Uphoff E; Vedanthan R; Wright J; Wright K; Zavala GA; Siddiqi N
    BMJ Open; 2022 Feb; 12(2):e051810. PubMed ID: 35172996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
    O'Malley N; Coote S; Staunton FM; O'Connor E; Clifford AM
    PLoS One; 2023; 18(11):e0294193. PubMed ID: 37956176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Core Outcome Set for Studies on Cardiac Disease in Pregnancy (COSCarP): a study protocol.
    D'Souza R; Hall C; Sermer M; Siu S; Silversides C
    Trials; 2020 Mar; 21(1):300. PubMed ID: 32228655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agreement on what to measure in randomised controlled trials in burn care: study protocol for the development of a core outcome set.
    Young A; Brookes S; Rumsey N; Blazeby J
    BMJ Open; 2017 Jul; 7(6):e017267. PubMed ID: 28669969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey.
    Li G; Zhou L; Ouyang W; Xuan M; Lu L; Li X; Wen Z; Chen X
    Trials; 2019 Jan; 20(1):14. PubMed ID: 30612586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET).
    Bateman M; Evans JP; Vuvan V; Jones V; Watts AC; Phadnis J; Bisset L; Vicenzino B
    Trials; 2021 May; 22(1):339. PubMed ID: 33971941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The outcomes of Perthes' disease of the hip: a study protocol for the development of a core outcome set.
    Leo DG; Leong WY; Gambling T; Long A; Murphy R; Jones H; Perry DC
    Trials; 2018 Jul; 19(1):374. PubMed ID: 30005667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A core outcome set for patient-reported dysphagia for use in head and neck cancer clinical trials: An international multistakeholder Delphi study.
    Manduchi B; Fitch MI; Ringash JG; Howell D; Martino R
    Head Neck; 2024 Apr; 46(4):831-848. PubMed ID: 38204219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake of core outcome sets by clinical trialists in China: a protocol.
    Qiu R; Fan X; Wang W; Clarke M; Chen Z; Liu S; Williamson P; Shang H
    F1000Res; 2023; 12():1030. PubMed ID: 38585230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a core outcome set for the evaluation of interventions to enhance trial participation decisions on behalf of adults who lack capacity to consent: a mixed methods study (COnSiDER Study).
    Shepherd V; Wood F; Robling M; Randell E; Hood K
    Trials; 2021 Dec; 22(1):935. PubMed ID: 34924004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol.
    Qiu R; Li M; Zhang X; Chen S; Li C; Shang H
    Trials; 2018 Oct; 19(1):541. PubMed ID: 30290840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMMPACT-recommended outcome measures and tools of assessment in burning mouth syndrome RCTs: an international Delphi survey protocol.
    Carey B; Farag AM; Nasri-Heir C; Klasser GD; Ariyawardana A; Chmieliauskaite M; Sardella A; Carlson CR; Miller CS; Mejia L; O'Neill FE; Albuquerque R
    Trials; 2020 Aug; 21(1):711. PubMed ID: 32787910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.